NCT03060057 (U-Propel) is a clinical trial of U2 Knee™ System in Osteo Arthritis Knee, sponsored by United Orthopedic Corporation.

Who is sponsoring NCT03060057?

NCT03060057 is sponsored by United Orthopedic Corporation.

What drugs are being tested in NCT03060057?

Interventions in NCT03060057: U2 Knee™ System.

What condition does NCT03060057 study?

NCT03060057 studies Osteo Arthritis Knee.

Is NCT03060057 still recruiting?

NCT03060057 is currently status unknown. Last updated 5 June 2023.

Last reviewed 2023-06-05 · How we verify

NCT03060057: U-Propel

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - "U-Propel Study"

Status unknown Last updated 5 June 2023

What this trial tests

trial testing U2 Knee™ System in Osteo Arthritis Knee in 200 participants. Status unknown.

Timeline

30 March 2017

Primary endpoint
30 March 2024

30 March 2026

Quick facts

Lead sponsor	United Orthopedic Corporation
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	30 March 2017
Primary completion	30 March 2024
Estimated completion	30 March 2026
Sites	4 locations across United States

Drugs / interventions tested

U2 Knee™ System

Conditions studied

Osteo Arthritis Knee — all drugs for Osteo Arthritis Knee →

Sponsor

United Orthopedic Corporation

Who can join

Adults 18 to 75, any sex, with Osteo Arthritis Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate both short and long term clinical performance and safety of the commercially available U2 Knee™ System.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteo Arthritis Knee

Currently open trials in the same condition.

NCT07258693 — Multimodal Treatment of Knee Osteoarthritis: Therapeutic Exercise and Noninvasive Neuromodulation (NESA) Versus Therapeu · NA · active not recruiting
NCT07141316 — Effects of Blood Flow Restriction Combined With Electrostimulation After Knee Arthroplasty · NA · active not recruiting
NCT06485843 — An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Jo · Phase 2 · recruiting
NCT06965946 — Intermittent Hypoxia-Hyperoxia Combined With Physical Therapy for Knee Osteoarthritis · NA · recruiting
NCT06058169 — Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03060057 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by United Orthopedic Corporation
Last refreshed: 5 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03060057.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing